Single-blind randomised multicentre trial comparing heparin and streptokinase treatment in recent myocardial infarction.
D000208:Acute Disease; D001219:Aspartate Aminotransferases / Q000097:blood; D001780:Blood Coagulation Tests; D001799:Blood Sedimentation; D002986:Clinical Trials as Topic; D003374:Coumarins / Q000627:therapeutic use; D003402:Creatine Kinase / Q000097:blood; D004562:Electrocardiography; D004912:Erythrocytes / Q000032:analysis; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D005500:Follow-Up Studies; D006400:Hematocrit; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D007275:Injections, Intravenous; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality; D011239:Prednisolone / Q000627:therapeutic use; D013300:Streptokinase / Q000627:therapeutic use*
D003374:Coumarins; D005340:Fibrinogen; D006493:Heparin; D011239:Prednisolone; D001219:Aspartate Aminotransferases; D003402:Creatine Kinase; D013300:Streptokinase